CD36 and obesity disorder: CD36 is well established in promoting the formation of atherosclerotic lesions (18); however, its contributions to the earlier stages of disease processes that predate lesion formation (i.e., endothelial dysfunction) and whether CD36 expression or function is influenced by specific adipose tissues in obesity remain unknown.